X-linked hypophosphataemia (XLH): Early Recognition and Proactive Management

X-linked hypophosphataemia (XLH): Early Recognition and Proactive Management is organized by EXCEL Continuing Education.

Released: May 11, 2020
Expires: May 11, 2021

Accreditation:
Designation Statement:
EXCEL Continuing Education designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credits™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Description:
X-linked hypophosphataemia (XLH) is the most common cause of inherited phosphate wasting and is associated with severe complications such as rickets, lower limb deformities, pain, poor mineralization of the teeth and disproportionate short stature in children. Characteristics and severity of XLH vary between patients. Because of its rarity, the diagnosis and specific treatment of XLH are frequently delayed, which has a detrimental effect on patient outcomes.

In this CME-accredited activity, an endocrinology expert will discuss strategies for improving early detection of XLH by recognizing clinical signs and symptoms, provide guidance for treatment initiation and ongoing optimal therapeutic management through sample case scenarios that may be seen in clinical practice.

Educational Objectives:
At the conclusion of this activity, participants should be able to:
• Discuss clinical manifestations, signs and symptoms of XLH in children 
• Review of phosphate homeostasis
• Describe an approach to the evaluation of hypophosphatemia
• Describe treatment options for XLH